WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006122003) DIARYL-PURINE, AZAPURINES AND -DEAZAPURINES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF HIV
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/122003    International Application No.:    PCT/US2006/017677
Publication Date: 16.11.2006 International Filing Date: 05.05.2006
IPC:
C07D 487/04 (2006.01), C07D 473/30 (2006.01), C07D 473/34 (2006.01), C07D 473/38 (2006.01)
Applicants: ARDEA BIOSCIENCES, INC. [US/US]; 300 Hyland Avenue, Costa Mesa, CA 92626 (US) (For All Designated States Except US).
GIRARDET, Jean, Luc [FR/US]; (US) (For US Only).
KOH, Yung-hyo [KR/US]; (US) (For US Only).
SHAW, Stephanie [US/US]; (US) (For US Only).
KIM, Hong Woo [KR/US]; (US) (For US Only)
Inventors: GIRARDET, Jean, Luc; (US).
KOH, Yung-hyo; (US).
SHAW, Stephanie; (US).
KIM, Hong Woo; (US)
Agent: WATSON, Karen, J.; Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto, CA 94304 (US)
Priority Data:
60/678,667 05.05.2005 US
Title (EN) DIARYL-PURINE, AZAPURINES AND -DEAZAPURINES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF HIV
(FR) DIARYL-PURINE, -AZAPURINES ET -DEAZAPURINES INHIBITEURS NON NUCLEOSIDIQUES DE LA TRANSCRIPTASE INVERSE UTILISES DANS LE TRAITEMENT DU VIH
Abstract: front page image
(EN)This application concerns certain 2-phenylamino-6-aryl amino-, 6-aryloxy-, and 6- arylthio- purines, -azapurines and -deazapurines. These compounds are non-nucleoside reverse transcriptase inhibitors and have potential as anti-HIV treatment.
(FR)L'invention concerne certains composés 2-phénylamino-6-aryl amino-, 6-aryloxy-, et 6- arylthio- purines, -azapurines et -déazapurines. Ces composés sont des inhibiteurs non nucléosidiques de la transcriptase inverse et peuvent être efficacement utilisés dans le traitement du VIH.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)